B cell alterations during BAFF inhibition with belimumab in SLE-Reference-Cited by-同舟云学术

B cell alterations during BAFF inhibition with belimumab in SLE

Published:2019-02 Issue: Volume:40 Page:517-527
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Ramsköld Daniel,Parodis Ioannis,Lakshmikanth Tadepally,Sippl Natalie,Khademi Mohsen,Chen Yang,Zickert Agneta,Mikeš Jaromír,Achour Adnane,Amara Khaled,Piehl Fredrik^ORCID,Brodin Petter,Gunnarsson Iva,Malmström Vivianne^ORCID

Funder

Swedish Research Council

Swedish Rheumatism Association

King Gustaf V's 80-year Foundation

Swedish Heart-Lung Foundation

Foundation in memory of Clas Groschinsky

Professor Nanna Svartz Foundation

Stockholm County Council

Karolinska Institutet

Biogen

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference45 articles.

1. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years;Chambers;Rheumatology (Oxford),2009

2. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China;Mok;Arthritis Rheum,2011

3. Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus;Urowitz;J Rheumatol,2008

4. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments;Liossis;Expert Opin Pharmacother,2014

5. Genetic and epigenetic fine mapping of causal autoimmune disease variants;Farh;Nature,2015

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the dynamics of B lymphocytes in systemic lupus erythematosus patients treated with belimumab through longitudinal single-cell RNA sequencing;Rheumatology;2024-07-22

2. Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses;Stem Cell Research & Therapy;2024-07-18

3. Current cell therapies for systemic lupus erythematosus;Stem Cells Translational Medicine;2024-06-26

4. Frequency and predictors for early-achieved lupus low disease activity state in systemic lupus erythematosus patients treated with telitacicept or belimumab: A real-life, single-center observational study;Frontiers in Immunology;2024-06-14

5. Targeting T-bet expressing B cells for therapeutic interventions in autoimmunity;Clinical and Experimental Immunology;2024-04-22